公司資料
Nuvectis Pharma 股價、新聞與催化劑
- 股票代碼:
- NVCT
- 交易所:
- NYSE
- 產業:
- Biopharma
- 所在地:
- United States
股票表現
17.76 USD (-3.84%)
收盤價
最後更新: 2026年11月5日
252M USD
市值
股價為何變動
截至 2026年11月5日，NVCT 下跌 3.84%，收於 $17.76。目前新聞監測窗口內未發現新的同公司新聞。
公司概覽
業務概覽
Nuvectis Pharma is an oncology company focused on targeted therapies for difficult cancers. Its development story is centered on precision oncology and smaller, data-sensitive programs.
所在地與產業分類
Headquartered in the United States and listed on NASDAQ, Nuvectis sits in specialty oncology biotechnology.
商業模式特徵
The business depends on proof-of-concept, program prioritization, and the ability to build a differentiated oncology franchise.
生技產業定位
Nuvectis is a small-cap oncology catalyst name whose valuation can move sharply on early data.
未來催化劑
- Nuvectis’s catalysts are NXP900 and NXP800, the two oncology assets that define the story. The market will care about whether either program can show real differentiation.
近期新聞
新聞標題由機器翻譯，詳情為英文原文。
- 01
- 02
- 03
- 04
- 05
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。